peripheral effects of nicotine
sympathomimetic = increased HR, increased BP, increased respiration, skin vasoconstriction (blood vessels are less active = cold to touch + skin wrinkles faster); increased smooth muscle activity; parasympathomimetic = stomach muscles will contract more (natural laxative)
central effects of nicotine
nausea (bc of activation of vomiting center), arousal (arousal of midbrain areas), + improvements in motor + cognitive performance (attention, short term episodic memory, + motor skills)
subjective effects of nicotine
stimulation, mood enhancement/pleasure, increased DA release in NAc tied to reinforcing effect (nAchRs are in mesolimbic pathway), + rapid blood absorption makes it more addicting
Tobacco Use Disorder (TUD)
3 major criteria; larger quantities of tobacco consumed than intended, tolerance for nicotine, + withdrawal symptoms after cessation of use
Nicotine withdrawal/dependence
complex because nicotine impacts many systems in the body + the brain; cognitive, emotional/psychological, + physical withdrawal symptoms; decreased HR, increased eating, insomnia, difficulty concentrating, craving, irritability, anxiety, etc.
nicotine physical dependence
most symptoms develop after several days, peak after a week; women experience stronger dependence bc they have more CYP2A6
nicotine psychological dependence
strong craving to return to nicotine use, no matter how many years they have been sober
harmful effects of smoking tobacco
increased risk of cardiovascular diseases (coronary heart disease + stroke), lung cancer, other forms of cancer, + respiratory diseases (chronic bronchitis + emphysema), nicotine can pass placental barrier = increases miscarriage, + stillbirth, baby’s risk of developing respiratory problems, birth defects
harmful effects of smokeless tobacco
cardiovascular risks, gum disease, damage to tooth enamel, loss of teeth, oral cancer, cancer of jaw, pharynx, + neck
negative effects of vaping
vapes contain carcinogenic properties + can damage lungs, breathing problems
psychomotor stimulants
drugs that enhance wakefulness and alertness, reduce fatigue + whose primary mechanism of action is to increase neurotransmission at monoaminergic synapses (dopamine, epinephrine, norepinephrine, + serotonin)
natural psychomotor stimulants
ephedrine (derived from an herb), cathinone (khat), cocaine (Erythroxylum coca)
Ephedra sinica
used in traditional chinese medicine for 5000+ yrs, ephedrine is chemically similar to epinephrine (sympathetic nervous system stimulant), originally used to treat asthma (bronchodilator + decongestant)
Catha edulis (Khat)
perinnial shrub found thru/out East Africa, cathinone is chemically similar to amphetamine, provides energy + reduces fatigue
Erythroxylum coca (cocaine)
dated back to 2500 BCE, sacred to Incas; chemically isolated in 1860 by Albert Neimann; extracted from leaves of coca bush in South America, produces euphoric effect
synthetic psychomotor stimulants
amphetamine, methamphetamine, + cathinone derivatives (bath salts)
cocaine in late 1800s
first local anesthetic, added to various beverages (Vin Mariani wine + Coca Cola until 1903); also thought to have therapeutic properties
Harrison Narcotics Tax Act (1914)
imposed taxes on sale, distribution, manufacturing, important, + distribution of coca leaves, opium, or any derived product; still allowed physicians to prescribe cocaine (could not use cocaine for pharmacotherapeutic purposes)
cocaine manufacturing
takes place in remote jungle labs where raw product undergoes a series of chemical transformations; Colombia produces 90% of cocaine powder reaching US
cocaine as local anesthetic
@ high local concentrations, cocaine inhibits voltage-gated sodium channels = blocking nerve signals for somatosensory/pain perception (procaine and lidocaine)
cocaine scheduling
cocaine is schedule 2 bc it has high misuse potential but still has some medicinal properties/uses (primarily topical local anesthetic for upper respiratory tract + reduce bleeding of mucous membranes in mouth, throat, + nasal cavities)
subjective/euphoric effects of cocaine
depends on how quickly cocaine reaches brain, faster it reaches = more rapid onset; IV (intravenous > INH/S (inhalation/smoking) > IN (intranasal) > PO (oral); improved mood, euphoria
mild/moderate effects of cocaine
mood amplification (euphoria + dysphoria), heightened energy, insomnia, motor excitement, talkativeness, hyperactive ideation, increased sexual interest, anger, mild to moderate anorexia, + inflated self-esteem
severe effects of cocaine
irritability, hostility, anxiety, extreme energy or exhaustion, total insomnia, compulsive motor stereotypies, rambling, disjointed flight of ideas, decreased sexual interest, possible extreme violence, total anorexia, + delusions of grandiosity
absorption of cocaine
cocaine is weak base (not good absorption), traditionally mixed with limestone so it raises pH of saliva which in turn increases absorption in the mouth
cocaine routes of administration
insufflation, IV (dissolved cocaine HCl), smoked (free base + crack)
cocaine distribution
readily crosses BBB, distributes to the brain
free base
cocaine HCl + ammonia and then extracted; more pure
crack
cocaine HCl mixed w/ sodium bicarbonate, dried into cakes; removes ionic charge = increased lipid solubility, lower melting point = allows vapor inhalation
absorption of amphetamines
amphetamines are weak base (not good absorption), depends on route of admin; two chemical forms active differently bc of chemical orientation
absorption of methamphetamine
compared to AMPH, more potent, more lipid soluble, chemically stable, + better BBB penetration
AMPH route of administration
amphetamines most potent by injection or inhalation; methamphetamines can be smoked, injected, or snorted
distribution of methamphetamine
more lipid soluble = can get into brain easily
metabolism of psychostimulants
all metabolized in the liver, although up to 40% of amphetamine may be excreted unaltered bc absorption is so low
excretion of psychostimulants
depends on pH of the urine (what is in the stomach), AMPH half-life 16-36 hours at basic pH, but as little as 7 hours w/ acidic pH; cocaine half-life 1 hour
presynaptic mechanism of cocaine
cocaine has binding site on dopamine transporter which blocks its activity, also blocks reuptake of norepinephrine + serotonin = more monoamine transmission in mesolimbic reward system; quickly binds + quickly comes off
presynaptic mechanism of apmhetamine
competitive substrate releasing agent; AMPH sneaks into cell, which allows it to sneak into vesicles, it causes vesicles to empty their contents, it reverses the transporter (release instead of reuptake), + inhibits enzymes (like MAO enzymes) that break down the neurotransmitter; massive increase in DA, NE, + serotonin
amphetamine vs methamphetamine
methamphetamine is more potent + faster acting, more lipid soluble + chemically stable, and has better BBB penetration; meth has additional methyl group
amphetamines in ADHD treatment
absorbed poorly from digestive system; slow/poor absorption creates more sustained lvl of amphetamine, advantage for medicinal use (d-Amphetamine = Adderall + Methylphenidate = Ritalin); increase NE + DA signaling in PFC = therapeutic effect (brings transmission lvls to “normal”)
animal models of psychostimulant reinforcement
rats will work on fixed ratio schedule + progressive ratio schedule to self-administer cocaine; depends on access; limited access = administer in steady manner, controlling cocaine intake; unlimited access = animals will binge; if provided w/ other rewarding behaviors, will decrease cocaine self-administration
cocaine “rush”
rapid onset of an acute/intense state of euphoria induced by cocaine reaching brain in seconds (via smoking or IV injection)
acute effects of cocaine
local anesthetic, activation of sympathetic nervous system, burst of energy + sense of wellbeing, rush that lasts b/t 20-30 minutes
acute effects of amphetamines
similar to cocaine; “rush” that can last up to 24 hours, increased wakefulness (insomnia), increased libido, increased HR + BP, enhanced mood (intense euphoria)
psychostimulant dependence + withdrawal
crash anhedonia, compensatory increases in sleeping + eating; anxiety, agitation, depression, + drug cravings that can last for a while depending on frequency + extent of use, + long term cognitive dysfunction (reduction in PFC)
crash/comedown anhedonia
period of depression + lethargy that usually begins 24 hours after drug cessation
monoamine psychosis
symptoms similar to schizophrenia; delusions, hallucinations, ‘formication’
psychological effects of psychosimulants
elevation of mood euphoria, increased vigilance, reduction of mental fatigue, sleep prevention; addictive properties, memory deficits
physiological effects of psychostimulants
increased HR, BP, vasocontriction, brochodilation, appetite suppression, over-driving fight or flight response, sleep prevention; neurotoxicity (death of neurons)
performance effects of psychostimulants
increased endurance, reduced physical fatigue; banned in athletic competitions, creates narrowed focus (reduces driving performance), repetitive motor behavior in animals + humans
punding
compulsive + repetitive task by humans when under the influence of psychostimulants
chronic harmful effects of psychostiulants
physical consequences = severe weight loss + myriad of dental issues (mostly due to malnutrition + lack of hygiene, esp. if smoked); reduced cortical activity (death of neurons); pharmacodynamic tolerance (downregulation of receptors); cell death and/or reduced neurogenesis (loss of brain volume)
formication
sensation of bugs on the skin as a result of repetitive psychostimulant use
caine reaction
overdose on cocaine, 2 phases; severe headaches, nausea, convulsions; then respiratory depression + cardiac arrest (which ultimately causes death)
original use of opium
in Mesopotamia by the Sumerians, valued the poppy plant + probably used it medicinally for its analgesic effects
origins of opium
originated in Asia + later Mediterranean regions, traders brought it to China in 9th century, smoking opium created addictions fueled by British-owned opium from India; Greek physicians Hippocrates + Galen recommended opium for just about everything
opium in Europe + Americas
opium use was widespread in Britain + US at all lvls of society in mid-1800s, advertised as “cures”, available by mail order
source of opium
derived from latex (“opium milk”); scrapped off the seed pods of poppy plant, compressed into cakes + dried
psychoactive extracts of opium
morphine (10%), codeine (2.5%), + thebaine (1%)
opioid derivatives (semi-synthetic)
heroin (from morphine), hydrocodone (Vicodin, from codeine), oxycodone (Percoset, from thebaine), + buprenorphine (Suboxone, from thebaine)
synthetic opioids
methadone, meperidine (Demerol), fentanyl, carfentanil, + many more
countries that still produce illicit opioids
“The Golden Triangle”; Afghanistan; China ships base chemicals to Mexico where they are further processed + then fentanyl is smuggled into U.S via U.S-Mexico border
fourth wave of overdose crisis
more than just opioids, overdoses as a result of opioids mixed w/ other psychoactive substances (opioids + stimulants); cannot consider it “just” opioids
regional differences in stimulant-related overdoses
methamphetamine more prevalent in mississippi + southern states, cocaine is more prevalent in northeast, immigrant, Indian, + black communities affected disproportionately, + more men overdose on fentanyl than women
treatments for StimUDs
no treatment available right now
contingency management (CM)
behavior change technique based upon the principles of operant conditioning where reinforcement is provided contingent on the occurrence of a target behavior consistent with reduced cocaine and/or methamphetamine use; highly effective but expensive
challenges of contingency management
no regulated guidelines, ppl are generally resistant to the concept, expensive/difficulty financing, + regulatory obstacles
effectiveness of CM
more effective when reinforcer is provided @ higher rather than lower levels, provided more immediately, + highly probable of being delivered
methods to prevent misuse of opioids + overdoses
interventions, early screening, more accessible healthcare, more research on pain + addiction, better practices for pain management, non-addictive strategies to manage chronic pain, new medications + tech to treat OUDs, improved overdose prevention + reversal interventions, comprehensive
3 medications approved by FDA to treat OUD
methadone (full agonist at MOR), buprenorphine (partial agonist at MOR), + extended-release naloxone (antagonist at MOR); stigmatized bc people do not understand medicated-assisted treatments
naloxone
fundamental for reversing opioid overdoses, antagonist at MOR; rapidly + fully reverses opioid overdose
OUDs + criminal justice settings
60% of prison population has SUD, treating b/4 release can reduce risk of overdose + reincarceration, more likely to overdose after being released bc they take high dose + their body cannot handle it (behavioral tolerance)
routes of administration of opioids
pharmacological use = morphine + codeine usually oral administration bc no acute euphoric effect + easy to manage blood lvls; recreational use = usually injected, smoked, or snorted (not usually taken orally) bc it maximizes euphoric effect (intense euphoria + rapid onset)
designer opioids
modified versions of controlled substances (improves potency, easy to make + cheaper)
Krokadil
derived from codeine, active ingredient = desomorphine, powerful analgesic, results in toxic byproducts that can cause scaly, gangrenous wounds
morphine vs heroin
morphine = acts directly on central opioid receptors; heroin = has additional acetyl groups which helps it to cross the BBB but no impact on receptor
heroin
schedule I drug; derived from morphine, has 2 additional acetyl groups that greatly improved lipid solubility; once heroin gets into brain, enzymes metabolize it back into morphine (which causes psychoactive effects)
pkA of morphine
pH = 8.5, makes it a base = poor absorption from the GI tract; only 15% gets to brain, significant first-pass metabolism via CYP3A4 enzymes in liver + gut break it down a lot
opioid absorption
morphine is base = poorly absorbed from GI tract (good for steady state levels); heroin is usually snuffed or smoked (IV fallen into disfavor)
opioid distribution
heroin passes BBB easily but must be metabolized back into morphine; morphine has poor lipid solubility but high affinity for receptors; many opioids are bound to blood proteins which extends their half-life
opioids well-absorbed in the gut
methadone, codeine, + oxycodone bc metaboized by different family of enzymes im GI tract which does not affect their bioavailability as much as other opioids
contemporary opioid use
1960s = Vietnam War vets brought back high grade opioid products with them + greater public acceptance of drug use + experimentation; present = opioids have become one of the most highly prescribed of all drugs (declining in recent years, peaked in 2012)
US drug overdose deaths per year
64% of ALL drug overdose deaths in US from April 2020 - April 2021 were specifically attributed to opioids (like fentanyl)
COVID-19 drug overdose deaths
increased drastically, 55% increase in opioid related overdoses + 47% increase in psychostimulant related overdoses
major opioid receptors
metabotropic; Mu (or MOR), Kappa, Delta, + ORL1 (nociception receptors; opioid-receptor like, in peripheral + spinal cord)
Mu opioid receptors (MOR)
primarily for analgesia + euphoric effect, all exogenous opioids bind to it; most important for sensing pain in spinal cord
distribution of opioid receptors
concentrated in midbrain (periaqueductal gray = pain perception), thalamus, hippocampus, ventral striatum, + olfactory bulbs; mu receptors thru/out brain + spinal cord
periaqueductal gray (PAG)
primarily for pain perception; can increase or decrease sensitivity to pain
presynaptic opioid receptor
inhibit VGCa2+ channels = decrease in neurotransmitter release (glutamate, GABA, etc)
postsynaptic opioid receptor
activate a variety of K+ channels to hyperpolarize neurons (K+ flows out of the neuron); opioid is inhibitory neuromodulator
endorphins
greatest affinity for mu receptors, “morphine within”, analgesia + reinforcement
enkephalins
greatest affinity for delta receptors, for analgesia + reinforcement
dynorphins
greatest affinity for kappa receptors, analgesia + dysphoria
nociceptin
greatest affinity for ORL1 receptors, regulate signals abt pain in peripheral + spinal cord (analgesia)
NAc opioid-induced DA release
beta endorphins bind presynaptically on GABAergic neuron in the VTA = blocked release of GABA; dopaminergic neuron is disinhibited = increased DA release to NAc = increased DA release in NAc to ventral pallidum (drive/motivated behavior)
mu opioid receptor competitive agonists
morphine, methadone, LAAM, fentanyl; mild-to-moderate binding affinity = heroin + codeine converted back into morphine in brain, short-acting forms = powerful “rush” (heroin, morphine, fentanyl), long-acting forms = weak “rush” (codeine, methadone)
mu opioid receptor competitive antagonists
work by competing for opioid binding sites + preventing exogenous opioid agonists from binding to MORs, no intrinsic efficacy of their own
Naloxone (Narcan)
high MOR binding affinity, short half-life + very rapid onset when given IV or intranasally; used to treat opioid overdose
Naltrexone
longer duration of action; blocks euphoric effect of opioids (and other drugs), used to treat many substance use disorders
opioids + analgesia
reduce sensation of physical pain (heat or cold, physical damage + organ damage) + emotional reaction to pain
physiological effects of opioids
nausea + vomiting (activation of MORs in brainstem region that controls vomiting), constipation (activation of opioid receptors in gut = inhibitory effect on motility), profuse sweating, pinpoint pupils, + sleep/sedation (produces drowsiness but long-term can cause insomnia)